by Jeanine Verbeek | Feb 17, 2026
Startups Back to overview From large scale patient data to precision therapeutics We aim to substantially improve health outcomes in two large and rapidly growing patient populations: (1) patients with combined heart failure (HF) and diabetes, and (2) individuals...
by Jeanine Verbeek | Feb 17, 2026
Startups Back to overview Immunara is developing a novel immune-priming technology based on single domain antibodies to direct patients’ own immune systems against cancer. Immunara is developing a novel precision immunotherapy designed to prime the immune...
by Jeanine Verbeek | Feb 17, 2026
Startups Back to overview Tolvac Therapeutics develops tolerogenic therapies to cure autoimmune diseases using proprietary platform technology Millions of people worldwide suffer from rheumatoid arthritis (RA), especially in developed countries where this condition...
by Jeanine Verbeek | Feb 6, 2026
Startups Back to overview MYRIAGON develops effective and non-addictive analgesics for neuropathic pain. MYRIAGON develops effective, non-addictive, oral analgesics for neuropathic pain. We have discovered a novel analgesic for chemotherapy induced peripheral...
by Janeska de Jonge | Dec 2, 2024
Startups Back to overview True targeted therapies for solid tumors Lumox is innovating cancer therapy with its nanobody-targeted photodynamic therapy (nanobody-tPDT) platform. Unlike current targeted therapies such as monoclonal antibodies and antibody-drug...
